We are live on ! Find out more
JP

John Paulson Paulson & Co

AUM $2.58B
1-Year Est. Return 68.51%
 

John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.

This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$3.11B
AUM Growth
-$150M
Cap. Flow
-$127M
Cap. Flow %
-4.09%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
1
Closed
1

Sector Composition

Rank Sector Weight
1 Materials 49.56%
2 Healthcare 36.15%
3 Financials 13.54%
4 Technology 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPTA
1
Perpetua Resources
PPTA
$3.21B
$910M 29.23%
32,347,299
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$11.9B
$729M 23.42%
1,392,188
-315,334
-18% -$151M
AAMI
3
Acadian Asset Management
AAMI
$3.28B
$421M 13.54%
7,743,282
BHC icon
4
Bausch Health
BHC
$2.41B
$396M 12.71%
73,255,869
NG icon
5
NovaGold Resources
NG
$3.83B
$245M 7.86%
27,238,061
THM
6
International Tower Hill Mines
THM
$735M
$229M 7.36%
99,573,038
+29,333,650
+42% +$74.8M
AEM icon
7
Agnico Eagle Mines
AEM
$109B
$159M 5.11%
783,561
THRY icon
8
Thryv Holdings
THRY
$92.4M
$23.1M 0.74%
8,443,835
+4,096,765
+94% +$16.1M
FOLD
9
DELISTED
Amicus Therapeutics
FOLD
$469K 0.02%
+32,400
New +$464K
SOLS
10
Solstice Advanced Materials
SOLS
$8.92B
-1,395,787
Closed -$67.8M

Similar funds

John Paulson's Q1 2026 Portfolio in Review

As of Q1 2026, John Paulson held 10 positions worth $3.11B, down 4.6% from $3.26B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

John Paulson withdrew a net $127M in Q1 2026, closing 1 position and reducing 1 holding. Its most notable exit was Solstice Advanced Materials, an estimated $67.8M position sold in full.

By sector, the portfolio is most concentrated in Materials at 50% of assets, up from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, John Paulson opened a new position in Amicus Therapeutics worth $469K.

  • John Paulson's largest Q1 2026 buy was Amicus Therapeutics: 32,400 shares worth $469K.
  • John Paulson added most to International Tower Hill Mines in Q1 2026, an estimated $74.8M increase.
  • John Paulson's biggest Q1 2026 reduction was Madrigal Pharmaceuticals, cutting an estimated $151M.
  • John Paulson fully exited Solstice Advanced Materials in Q1 2026, selling an estimated $67.8M.
  • John Paulson's ten largest holdings make up 100% of its $3.11B portfolio in Q1 2026.
  • John Paulson opened 1 new position and closed 1 in Q1 2026.
  • John Paulson's portfolio value fell 4.6% quarter-over-quarter to $3.11B.

Based on Paulson & Co's 13F filing for Q1 2026, filed 15 May 2026.